GLEN ALLEN, Va., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for ...
A phase II study of oxaliplatin/5FU/bevacizumab and concurrent pelvic radiation in patients with simultaneous primary and metastatic rectal cancer: The Chrome-B trial ...
Please provide your email address to receive an email when new articles are posted on . In a two-stage, open-label, phase 2/3 clinical trial, researchers analyzed 301 patients (median age 47 years, 52 ...
GLEN ALLEN, Va., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the ...
On Tuesday, Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) announced that patent number 12150931 was issued by the United States Patent and Trademark Office on November 26, expanding the company's ...
Genotype "AC" is all about your blood and how it carries oxygen around your body. The "A" part is the normal type of haemoglobin, which does the job just fine. The "C" part is a bit different—it's a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results